Department of Neurology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Department of Neurology, Zhuji People's Hospital of Zhejiang Province, Shaoxing, China.
Mov Disord. 2019 Feb;34(2):291-297. doi: 10.1002/mds.27582. Epub 2018 Dec 27.
Very recently, the MYORG gene was identified as a novel causative gene for autosomal-recessive primary familial brain calcification.
To investigate the clinical, genetic, and neuroradiological characteristics of primary familial brain calcification patients with biallelic MYORG mutations in China.
We collected clinical and neuroradiological data of 169 Chinese patients with primary familial brain calcification, including 151 sporadic patients and 18 patients from 13 families compatible with an autosomal-recessive mode of inheritance. Mutational analysis of MYORG was performed in the cohort.
We identified four, including three novel, MYORG mutations segregating in four families with 5 patients: one nonsense mutation (c.1431C>A, p.Y477*), one missense mutation (c.687G>T, p.W229C), and two nonframeshift indels (c.348_349insCTGGCCTTCCGC, p.116_117insLAFR; c. 428_442delTGCACTTCTTCATCC, p.143_147delLHFFI). The 12-base-pair insertion, c.348_349insCTGGCCTTCCGC, was found in either homozygous or heterozygous state in 2 probands of our cohort and another Chinese primary familial brain calcification patient previously reported on in the literature. Haplotype analysis of our patients harboring the insertion indicated a founder effect in the ethnic Han Chinese population. To date, biallelic MYORG mutations have been reported in 17 patients (including our cohort). Most patients were symptomatic (13 of 17; 76.5%), and the most recurrent symptoms were movement disorders (10 of 17; 58.8%), cognitive decline (7 of 17; 41.2%), and cerebellar symptoms (6 of 17; 35.3%). All patients had calcifications on comprehensive cranial CT, most frequently located in the basal ganglia (17 of 17; 100%), cerebellum (17 of 17; 100%), subcortical white matter (14 of 17; 82.4%), and thalamus (13 of 17; 76.5%).
We confirmed MYORG as a novel causative gene for primary familial brain calcification and further expanded the mutational and phenotypic spectrum of MYORG-related primary familial brain calcification. © 2018 International Parkinson and Movement Disorder Society.
最近,MYORG 基因被鉴定为常染色体隐性遗传原发性家族性脑钙化的新致病基因。
研究中国常染色体隐性遗传 MYORG 双等位基因突变所致原发性家族性脑钙化患者的临床、遗传和神经影像学特征。
我们收集了 169 例原发性家族性脑钙化患者的临床和神经影像学资料,包括 151 例散发性患者和 13 个家族的 18 例符合常染色体隐性遗传模式的患者。对该队列进行了 MYORG 基因突变分析。
我们发现了四个突变,包括三个新的突变,在四个家系的 5 名患者中分离:一个无义突变(c.1431C>A,p.Y477*),一个错义突变(c.687G>T,p.W229C),和两个非移码插入(c.348_349insCTGGCCTTCCGC,p.116_117insLAFR;c.428_442delTGCACTTCTTCATCC,p.143_147delLHFFI)。12 个碱基对的插入,c.348_349insCTGGCCTTCCGC,在我们队列中的 2 个先证者和另一个以前文献报道的中国原发性家族性脑钙化患者中以纯合或杂合状态存在。携带插入物的我们患者的单体型分析表明汉族人群存在一个起源效应。迄今为止,双等位基因 MYORG 突变已在 17 名患者(包括我们的队列)中报道。大多数患者有症状(17 例中的 13 例;76.5%),最常见的症状是运动障碍(17 例中的 10 例;58.8%)、认知能力下降(17 例中的 7 例;41.2%)和小脑症状(17 例中的 6 例;35.3%)。所有患者的头颅 CT 均有钙化,最常见于基底节(17 例中的 17 例;100%)、小脑(17 例中的 17 例;100%)、皮质下白质(14 例中的 17 例;82.4%)和丘脑(17 例中的 13 例;76.5%)。
我们证实 MYORG 是原发性家族性脑钙化的一个新的致病基因,并进一步扩展了 MYORG 相关原发性家族性脑钙化的突变和表型谱。 © 2018 国际帕金森病和运动障碍学会。